This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0003319707310279v1 59/6/667    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Chen, J. P. Articles by King, S. Search for Related Content PubMed PubMed Citation Articles by Chen, J. P. Articles by King, S. Pubmed/NCBI databases Medline Plus Health Information Angioplasty Social Bookmarking                         What's this?

Late Angiographic Stent Thrombosis: The LAST Straw for Drug-Eluting Stents?

^* To whom correspondence should be addressed. E-mail: chenjackapollo{at}yahoo.com.

	Abstract

The long-term patency advantage of drug-eluting stents represents a quantum leap in the percutaneous treatment of ischemic heart disease. Although initial landmark trials demonstrated equivalent safety to bare-metal stents, subsequent follow-up analyses have suggested a slight late thrombotic risk. This widely publicized issue poses major public health implications for the medical and lay communities. However, available data indicate that this late risk is counterbalanced by the dramatic drug-eluting stent reduction in target lesion revascularizations, resulting in equivalent overall major adverse cardiovascular event rates than that of the bare-metal stents The recent Food and Drug Administration’s guidelines regarding these devices are delineated in detail. Specifically, compliance with dual antiplatelet therapy (minimum 1 year) is of paramount consideration in patient selection for drug-eluting stents. Moreover, when deployed for "on-label" indications, they provide significant restenosis advantage, with a slight late thrombotic risk but without overall increase in death or infarction.

First published on April 2, 2008, doi:10.1177/0003319707310279

Angiology 2009;59:667.

A more recent version of this article appeared on January 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?